Joshua T Brumm - Net Worth and Insider Trading
Joshua T Brumm Net Worth
The estimated net worth of Joshua T Brumm is at least $15 Million dollars as of 2024-11-10. Joshua T Brumm is the CEO & President of Dyne Therapeutics Inc and owns about 537,998 shares of Dyne Therapeutics Inc (DYN) stock worth over $15 Million. Joshua T Brumm is also the COO and CFO of Aravive Inc and owns about 33,545 shares of Aravive Inc (ARAV) stock worth over $1,345. Details can be seen in Joshua T Brumm's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joshua T Brumm has not made any transactions after 2024-03-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joshua T Brumm
Joshua T Brumm Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joshua T Brumm owns 4 companies in total, including Dyne Therapeutics Inc (DYN) , Kaleido Biosciences Inc (KLDO) , and Aravive Inc (ARAV) among others .
Click here to see the complete history of Joshua T Brumm’s form 4 insider trades.
Insider Ownership Summary of Joshua T Brumm
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DYN | Dyne Therapeutics Inc | 2024-03-11 | director & See Remarks |
KLDO | Kaleido Biosciences Inc | 2019-02-27 | See Remarks |
ARAV | Aravive Inc | 2017-10-19 | Chief Financial Officer |
2012-02-17 | VP of Corporate Development |
Joshua T Brumm Latest Holdings Summary
Joshua T Brumm currently owns a total of 2 stocks. Among these stocks, Joshua T Brumm owns 537,998 shares of Dyne Therapeutics Inc (DYN) as of March 11, 2024, with a value of $15 Million and a weighting of 99.99%. Joshua T Brumm also owns 33,545 shares of Aravive Inc (ARAV) as of October 19, 2017, with a value of $1,345 and a weighting of 0.01%.
Latest Holdings of Joshua T Brumm
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DYN | Dyne Therapeutics Inc | 2024-03-11 | 537,998 | 28.48 | 15,322,183 |
ARAV | Aravive Inc | 2017-10-19 | 33,545 | 0.04 | 1,345 |
Holding Weightings of Joshua T Brumm
Joshua T Brumm Form 4 Trading Tracker
According to the SEC Form 4 filings, Joshua T Brumm has made a total of 12 transactions in Dyne Therapeutics Inc (DYN) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Dyne Therapeutics Inc is the sale of 429,730 shares on March 11, 2024, which brought Joshua T Brumm around $11 Million.
According to the SEC Form 4 filings, Joshua T Brumm has made a total of 0 transactions in Aravive Inc (ARAV) over the past 5 years. The most-recent trade in Aravive Inc is the sale of 221 shares on October 19, 2017, which brought Joshua T Brumm around $3,381.
Insider Trading History of Joshua T Brumm
- 1
Joshua T Brumm Trading Performance
GuruFocus tracks the stock performance after each of Joshua T Brumm's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua T Brumm is -17.12%. GuruFocus also compares Joshua T Brumm's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua T Brumm within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joshua T Brumm's insider trading performs compared to the benchmark.
Performance of Joshua T Brumm
Joshua T Brumm Ownership Network
Ownership Network List of Joshua T Brumm
Ownership Network Relation of Joshua T Brumm
Joshua T Brumm Owned Company Details
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Joshua T Brumm is the director & See Remarks of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include director & 10 percent owner Dirk Kersten , See Remarks Richard William Scalzo , and Chief Operating Officer Susanna Gatti High .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Joshua T Brumm made 8 insider transaction in Dyne Therapeutics Inc (DYN) with a net sale of 1,161,154. Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 446,445 shares made by Dirk Kersten , a net sale of 327,516 shares made by Richard William Scalzo , and a net sale of 273,683 shares made by Susanna Gatti High .
In summary, during the past 3 months, insiders sold 1,954,064 shares of Dyne Therapeutics Inc (DYN) in total and bought 32,000 shares, with a net sale of 1,922,064 shares. During the past 18 months, 7,985,414 shares of Dyne Therapeutics Inc (DYN) were sold and 1,746,285 shares were bought by its insiders, resulting in a net sale of 6,239,129 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
Joshua T Brumm Mailing Address
Above is the net worth, insider trading, and ownership report for Joshua T Brumm. You might contact Joshua T Brumm via mailing address: Zeltiq Aesthetics Inc., 4698 Willow Road Suite 100, Pleasanton Ca 94588.